Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID-19 Pandemic.

Mercadé-Besora N, Guo Y, Du M, Li X, Ramírez-Anguita JM, Moreno A, Valente A, Villalobos F, Cheng IL, Carrasco-Ribelles LA, van Swieten MMH, Merkelbach M, Magoya M, Lasalvia P, Pericàs-Pulido P, Berg P, Bosco-Lévy P, Lillini R, Ribeiro R, Bagga TK, Ramella V, Khalid S, Mayer MA, Leis A, Jödicke AM, Burn E, Prieto-Alhambra D, Català M, Prats-Uribe A

Open source

DOI: 10.1002/acr.25331
Published: 2024 Aug
Container: Arthritis care & research
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/acr.25331,
  title = {Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID-19 Pandemic.},
  author = {Mercadé-Besora N and Guo Y and Du M and Li X and Ramírez-Anguita JM and Moreno A and Valente A and Villalobos F and Cheng IL and Carrasco-Ribelles LA and van Swieten MMH and Merkelbach M and Magoya M and Lasalvia P and Pericàs-Pulido P and Berg P and Bosco-Lévy P and Lillini R and Ribeiro R and Bagga TK and Ramella V and Khalid S and Mayer MA and Leis A and Jödicke AM and Burn E and Prieto-Alhambra D and Català M and Prats-Uribe A},
  year = {2024},
  journal = {Arthritis care \& research},
  doi = {10.1002/acr.25331},
  url = {https://doi.org/10.1002/acr.25331}
}

RIS

TY  - JOUR
TI  - Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID-19 Pandemic.
AU  - Mercadé-Besora N
AU  - Guo Y
AU  - Du M
AU  - Li X
AU  - Ramírez-Anguita JM
AU  - Moreno A
AU  - Valente A
AU  - Villalobos F
AU  - Cheng IL
AU  - Carrasco-Ribelles LA
AU  - van Swieten MMH
AU  - Merkelbach M
AU  - Magoya M
AU  - Lasalvia P
AU  - Pericàs-Pulido P
AU  - Berg P
AU  - Bosco-Lévy P
AU  - Lillini R
AU  - Ribeiro R
AU  - Bagga TK
AU  - Ramella V
AU  - Khalid S
AU  - Mayer MA
AU  - Leis A
AU  - Jödicke AM
AU  - Burn E
AU  - Prieto-Alhambra D
AU  - Català M
AU  - Prats-Uribe A
PY  - 2024
JO  - Arthritis care & research
DO  - 10.1002/acr.25331
UR  - https://doi.org/10.1002/acr.25331
ER  -

APA

N, M., Y, G., M, D., X, L., JM, R., A, M., A, V., F, V., IL, C., LA, C., MMH, V. S., M, M., M, M., P, L., P, P., P, B., P, B., R, L., R, R., TK, B., V, R., S, K., MA, M., A, L., AM, J., E, B., D, P., M, C., & A, P. (2024). Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID-19 Pandemic.. Arthritis care & research. https://doi.org/10.1002/acr.25331

Source records

pubmed · retrieved 2026-09-27T12:40:13.269Z